Deals In Depth: December 2018
Executive Summary
AC Immune and Eli Lilly teamed up in a $1.9 billion Alzheimer's deal. GSK's focused investment in oncology led to the $5.1 billion acquisition of Tesaro. Biopharma financing totaled $3.1 billion, half of which was from public offerings.